Thomas S. Dann

Thomas S. Dann is a highly experienced executive in the healthcare and venture capital sectors, currently serving as a Member of the Board of Advisors at Analytic Marketing, LLC, and President of MedLiquidity Corporation, which revolutionizes healthcare provider claims into AAA-rated securities. Dann holds significant roles in Cellphire Therapeutics, Inc. as Strategic Advisor and Vice President for Legal, Strategy & Investor Relations, as well as Director at HeMemics Biotechnologies, Inc. and Member of the Board of Advisors at Quidient, LLC. As the Founder and Managing Director of Castlehaven Advisors, LLC, Dann provides advisory services to early-stage companies and high net worth investors. Previously, Dann managed the Maryland Venture Fund and held director roles in various investment initiatives, contributing to economic development and job creation. Educational credentials include a Bachelor of Arts from Stanford University and a Doctor of Law from American University Washington College of Law.